Membrane Oxygenators Market Projected to Surpass US$ 166 million by 2032, Showing a 1.9% CAGR, Persistence Market Research [Yahoo! Finance]
FRESENIUS SE S/ADR (FSNUY)
NASDAQ:AMEX Investor Relations:
fresenius.com/index
Company Research
Source: Yahoo! Finance
regulatory approvals for innovative devices, indicating a dynamic and evolving landscape New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- According to a recently published report by Persistence Market Research, the global sales of Membrane Oxygenators Market reached US$ 134 million in 2021 and Projected to grow at a CAGR of 2% from 2022 to 2032, the market is expected to reach a valuation of US$ 166 million by 2032. The Membrane Oxygenators Market is strongly influenced by the prevalence of chronic diseases such as respiratory and cardiovascular diseases (CVD). The research indicates that approximately 655,000 Americans die from heart disease each year, with a ratio of 1:4, and around 805,000 Americans suffer from heart attacks annually. This is expected to drive the demand for membrane oxygenators in the forecast period. The growth of membrane oxygenators was heightened during the COVID-19 pandemic due to their broad application in the first two waves of the SAR-Cov-2 globally. By J
Show less
Read more
Impact Snapshot
Event Time:
FSNUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FSNUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FSNUY alerts
High impacting FRESENIUS SE S/ADR news events
Weekly update
A roundup of the hottest topics
FSNUY
News
- Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.Business Wire
- Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP [Yahoo! Finance]Yahoo! Finance
- Fresenius Targets Faster Earnings Growth After More Cost Cuts [BNN Bloomberg (Canada)]BNN Bloomberg
- Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections [Yahoo! Finance]Yahoo! Finance